[(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate

C35H36N3O8+ — CID 132532452

IUPAC[(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate
SMILESCC(=O)O[C@H]1[C@H](O)[C@@H](COCc2ccccc2)O[C@@H](OCc2ccc(Cn3cc[n+](C)c3)cc2)[C@@H]1N1C(=O)c2ccccc2C1=O
InChIInChI=1S/C35H36N3O8/c1-23(39)45-32-30(38-33(41)27-10-6-7-11-28(27)34(38)42)35(46-29(31(32)40)21-43-19-25-8-4-3-5-9-25)44-20-26-14-12-24(13-15-26)18-37-17-16-36(2)22-37/h3-17,22,29-32,35,40H,18-21H2,1-2H3/q+1/t29-,30-,31-,32-,35-/m1/s1
InChIKeyMOEHXSCZKJIWER-PVEIOGNQSA-N
MW626.69 g/mol
LogP2.78
Rot. Bonds11

About [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate

[(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate (PubChem CID 132532452) has the molecular formula C35H36N3O8+ and a molecular weight of 626.69 g/mol. Its IUPAC name is [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate.

Molecular Properties

Compound Name[(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate
PubChem CID132532452
Molecular FormulaC35H36N3O8+
Molecular Weight626.69 g/mol
Exact Mass626.25
IUPAC Name[(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate
SMILESCC(=O)O[C@H]1[C@H](O)[C@@H](COCc2ccccc2)O[C@@H](OCc2ccc(Cn3cc[n+](C)c3)cc2)[C@@H]1N1C(=O)c2ccccc2C1=O
InChIInChI=1S/C35H36N3O8/c1-23(39)45-32-30(38-33(41)27-10-6-7-11-28(27)34(38)42)35(46-29(31(32)40)21-43-19-25-8-4-3-5-9-25)44-20-26-14-12-24(13-15-26)18-37-17-16-36(2)22-37/h3-17,22,29-32,35,40H,18-21H2,1-2H3/q+1/t29-,30-,31-,32-,35-/m1/s1
InChIKeyMOEHXSCZKJIWER-PVEIOGNQSA-N
XLogP2.78
TPSA120.41 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds11
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500626.69
LogP ≤ 52.78
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate?
The IUPAC name of [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate (CID 132532452) is [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate.
What is the SMILES notation for [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate?
The canonical SMILES for [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate is CC(=O)O[C@H]1[C@H](O)[C@@H](COCc2ccccc2)O[C@@H](OCc2ccc(Cn3cc[n+](C)c3)cc2)[C@@H]1N1C(=O)c2ccccc2C1=O.
What is the InChIKey of [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate?
The InChIKey is MOEHXSCZKJIWER-PVEIOGNQSA-N. The full InChI is InChI=1S/C35H36N3O8/c1-23(39)45-32-30(38-33(41)27-10-6-7-11-28(27)34(38)42)35(46-29(31(32)40)21-43-19-25-8-4-3-5-9-25)44-20-26-14-12-24(13-15-26)18-37-17-16-36(2)22-37/h3-17,22,29-32,35,40H,18-21H2,1-2H3/q+1/t29-,30-,31-,32-,35-/m1/s1.
What are the key properties of [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate?
[(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate has a molecular weight of 626.69 g/mol, XLogP of 2.78, 11 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5S,6R)-3-(1,3-dioxoisoindol-2-yl)-5-hydroxy-2-[[4-[(3-methylimidazol-3-ium-1-yl)methyl]phenyl]methoxy]-6-(phenylmethoxymethyl)oxan-4-yl] acetate is sourced from PubChem (CID 132532452), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).